Johns Hopkins University
Baltimore, Maryland, 21205, United States
NCT Number: NCT03431493
More and more people are surviving after receiving life support for respiratory failure in the intensive care unit, but these patients often experience problems with depression and physical functioning that lead to reduced quality of life. There is a lack of treatment for these patients, with past research suggesting that treatment may be more successful if mental and physical health are addressed at the same time. This research evaluates whether a therapy delivered via telephone and home visits, combining treatment for depression and physical rehabilitation, is feasible and might help patients recover.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
Baltimore, Maryland, 21205, United States
A growing number of Acute Respiratory Failure (ARF) survivors are burdened by depressive symptoms and physical impairments that last for years after intensive care unit discharge. Notably, depressive symptoms are independently associated with subsequent development of new impairments in physical functioning. There is a lack of treatment options to address these impairments in ARF survivors, with past research suggesting combining treatment for mental and physical health might be more successful.
Therefore, this study is designed to evaluate:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will first receive a home visit from a physical therapist (PT) who will evaluate home safety and establish/verify the participant's exercise prescription. Within 1 week, an occupational therapist (OT) will visit the home to: 1) explain the purpose of behavioral activation (BA); 2) help the participant identify long-term recovery goals regarding "valued activities"; and 3) then, using the principles of BA, identify short-term goals for the next week and an action plan. The OT will then call the participant weekly (weeks 2-5) to review the status of the prior week's goals and use BA to set new goals for the upcoming week. The PT and OT will repeat home visits at week 6 to assess the participant's progress, and the OT will conduct phone calls every 2 weeks for weeks 8-12.
Time frame: End of intervention (12 weeks)
Total number of intervention visits completed per patient as a proportion of the number of intervention visits each patient is intended to complete.
Time frame: End of intervention (12 weeks)
Total number of intervention visits completed by all study participants as a proportion of total intervention visits expected in the study
Time frame: End of intervention (12 weeks)
Number of patients completing all study follow-up sessions as a proportion of the number of patients enrolled.
Time frame: End of intervention (12 weeks)
Average number of patients enrolled per month over 12 weeks
Time frame: End of intervention (12 weeks)
An instrument used to assess anxiety symptoms. Scores range from 0 to 21. A HADS score ≥8 indicates clinically important symptoms on either subscale (more symptoms).
Time frame: End of intervention (12 weeks)
An instrument used to assess depressive symptoms. Scores range from 0 to 21. A HADS score ≥8 indicates clinically important symptoms on either subscale (more symptoms).
Time frame: End of intervention (12 weeks)
The PHQ-8 uses a 4-point Likert scale to assess depressive symptoms. The score range is 0 to 27. Scores 5-9 indicate "mild" symptoms, 10-14 "moderate", and ≥20 "severe" depressive symptoms. Higher score more symptoms.
Time frame: End of intervention (12 weeks)
The AMPAC-CAT, a measure of physical function, has 269 items across three domains (basic mobility, daily activity and applied cognitive). The computer adaptive test requires a mean of 22 items from the item bank. Scores are norm-based (min 0 and mx 100). Higher scores indicate better function.
Time frame: End of intervention (12 weeks)
The EQ-5D-5L is an instrument developed by the EuroQol group to measure health status. The Eq-5D-5L has 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels, ranging from 1 (no problems) to 5 (extreme problems). The resulting health utility score ranges from -0.11 to 1.00. Higher scores indicate better health status.
Time frame: End of intervention (12 weeks)
Patient interview to assess the following end of study (ie ~12 weeks) variable: number of patients with inpatient readmissions
Time frame: end of intervention (12 weeks)
Patient interview to assess the following end of study (ie ~12 weeks) variable: number of participants who ever utilized outpatient mental health
Time frame: end of intervention (12 weeks)
Patient interview to assess the following end of study (ie ~12 weeks) variable: number of patients who ever utilized physical rehabilitation services
Time frame: End of intervention (12 weeks)
This is a 25-item scale that measures changes in avoidance and activation over the course of Behavioral Activation treatment using a 7 point scale (0=not at all to 6=completely). The scale is grouped into 4 subscales (Activation, Avoidance/Rumination, Work/School Impairment, and Social Impairment). To calculate a total score, items on all subscales other than Activation are reverse-coded and then an unweighted sum is computed. Score range 0 to 150. Higher scores indicate greater activation.
Time frame: End of intervention (12 weeks)
This is a 25-item scale with each item rated on a 5-point scale (higher scores indicating greater resilience). The total score ranges from 0 to 100.
Time frame: End of intervention (12 weeks)
Measure of adherence
Time frame: End of intervention (12 weeks)
Measure of adherence for intervention group
Time frame: End of intervention (12 weeks)
Measure of cognitive impairment. Score range 0 - 22. Higher scores indicate better cognitive function.
Time frame: End of intervention (12 weeks)
This is a measure the subjective response to a specific traumatic event (in this case - critical illness and associated ICU experience). The IES-R consists of 22 items, each rated on a 5-point scale; item scores are averaged to generate a mean total score (range: 0-4). Higher score indicates more stress symptoms.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: end of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A 28-item measure of coping strategies with responses provided using a 4-point Likert scale. Minimum score=2 to Maximum score=8. Higher score indicates greater use of the specified coping strategy.
Time frame: End of intervention (12 weeks)
A clinical interview to assess depressive symptoms. This is a qualitative assessment.
Johns Hopkins University
Other
A Pilot, Feasibility Randomized Controlled Trial of a Behavioral Activation And Rehabilitation Intervention To Improve Psychological And Physical Impairments In Acute Respiratory Failure Survivors
Acronym: BEHAB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06304493
Behavior, Health Behavior
Aurora, Colorado, United States
View Trial DetailsNCT03108118
Diaphragm Injury, Mechanical Ventilation Complication
Toronto, Ontario, Canada
View Trial DetailsNCT00120575
Bone Marrow Transplantation, Respiration Disorders
Oakland, California, United States
View Trial DetailsNCT07228676
Dyspnea, Oxygen
Poitiers, France
View Trial Details